# Publisher Correction: Impaired MC3T3-E1 osteoblast differentiation triggered by oncogenic HRAS is rescued by the farnesyltransferase inhibitor Tipifarnib

**Authors:** Yannik Andrasch, Moses Munene Ireri, Jonas Gander, Ann-Engelke Sabrina Timm, Saravanakkumar Chennappan, Miray Fidan, Melanie Engler, Ion Cristian Cirstea

PMC · DOI: 10.1038/s41598-025-98727-0 · 2025-04-22

## Full-text entities

- **Genes:** HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}
- **Chemicals:** Tipifarnib (MESH:C402769)
- **Cell lines:** MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409)

---
Source: https://tomesphere.com/paper/PMC12015491